RT Journal Article
T1 Liver cirrhosis and sarcopenia: a dreadful combination.
A1 Kuchay, Mohammad Shafi
A1 Martinez-Montoro, Jose Ignacio
A1 Llamoza-Torres, Camilo Julio
A1 Fernandez-Garcia, Jose Carlos
A1 Ramos-Molina, Bruno
K1 Fibrosis
K1 Sarcopenia
K1 Death
K1 Liver Cirrhosis
K1 Mortality
AB Patients with liver cirrhosis, irrespective of etiology, have increased risk of liver-related and all-cause mortality (1). Also, the severity of cirrhosis determines health outcomes. For instance, patients with compensated cirrhosis have a nearly five-fold increased risk of death, while those with decompensated cirrhosis have approximately a 10-fold increased risk compared with the general population (1). Furthermore, the median survival time of patients with compensated cirrhosis is 12 years, while it is only 1.8 years in those with decompensated cirrhosis (2). Moreover, the presence of intercurrent conditions, such as sarcopenia (loss of skeletal muscle mass and function) may also compromise the prognosis of patients with cirrhosis (3).
PB AME Publishing Company
SN 2304-3881
YR 2022
FD 2022-09-05
LK http://hdl.handle.net/10668/21770
UL http://hdl.handle.net/10668/21770
LA en
NO Kuchay MS, Martínez-Montoro JI, Llamoza-Torres CJ, Fernández-García JC, Ramos-Molina B. Liver cirrhosis and sarcopenia: a dreadful combination. Hepatobiliary Surg Nutr. 2022 Oct;11(5):729-731
DS RISalud
RD Jul 6, 2025